CTRI/2017/11/010513
Completed
未知
Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types. - Nil
ITC Life Sciences Technology Centre0 sites24 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ITC Life Sciences Technology Centre
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects in the age group 18 \- 55 years (both the ages inclusive).
- •Healthy male \& female subjects.
- •Subjects with Fitzpatrick skin type III to V.
- •Subjects willing to give a written informed consent.
- •Subjects willing to maintain the patch test in position for 24 hours.
- •Subject having not participated in a similar investigation in the past two weeks.
- •Subjects willing to come for regular follow up visits.
- •Subjects ready to follow instructions during the study period.
Exclusion Criteria
- •Infection, allergy on the tested area.
- •Skin allergy, antecedents or atopic subjects.
- •Athletes and subjects with history of excessive sweating.
- •Cutaneous disease which may influence the study result.
- •Subjects on oral corticosteroid with dose \>10mg/day.
- •Subjects participating in any other cosmetic or therapeutic trial.
- •Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To understand the safety of investigational products by assessing the irritation after patch application on human volunteers.CTRI/2012/06/002724ITC RD Centre24
Completed
Not Applicable
Safety testing of cosmetic products by patch testCTRI/2017/05/008582ITC Limited ITC Life Sciences Technology Centre35
Completed
Not Applicable
To check the test products safetyCTRI/2024/02/062575Transformative Learning Solutions Pvt Ltd24
Completed
Not Applicable
Safety assessment of products on skiCTRI/2019/03/018068ITC Life Sciences Technology Centre24
Completed
Phase 2
Skin Safety Study on Healthy Human SubjectsCTRI/2017/02/007849Dabur India Limited